查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529766

止血阀市场规模、份额、趋势分析报告：按类型、应用、最终用途、地区和细分市场预测，2024-2030 年

Hemostasis Valve Market Size, Share & Trends Analysis Report By Type, By Application (Angiography, Angioplasty), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

止血阀市场规模及趋势

2023年全球止血阀市场规模预估为1.748亿美元，预估2024年至2030年复合年增长率为5.8%。心血管疾病盛行率的增加、支持性法律规范、老年人口的增加以及技术进步正在显着推动市场成长。根据世界心臟联盟2023年发布的报告，心血管疾病（CVD）在全球造成严重影响，影响全球超过5亿人，预计2021年将增加到2,050万人左右。这增加了对血管造影术和血管成形术等诊断和治疗程序的需求，而止血阀对于控制血流和确保导管插入期间患者的安全至关重要。

对微创手术的偏好也是推动市场成长的关键因素。微创手术与传统开放性手术相比具有许多优势，包括减轻疼痛、缩短住院时间、加快復原时间和降低併发症风险。因此，对促进这些手术的医疗设备的需求不断增长。止血阀对于微创导管介入至关重要，因为它们可以精确控制血流并防止手术过程中渗漏。心臟病学和其他医疗领域向微创技术的转变正在推动止血阀的采用。

由于出生率下降和医疗进步导致预期寿命延长，世界人口结构正在经历人口老化的显着转变。据世界卫生组织 (WHO) 称，到 2050 年，全球 60 岁及以上的人口数量预计将增加一倍，达到约 21 亿人。这种人口结构的变化凸显了老年人与老龄化相关的疾病，包括心血管疾病（CVD）的盛行率不断增加。根据美国心臟协会2023年11月发表的一篇论文，心臟衰竭是一种广泛且多方面的心血管疾病，影响着超过670万美国，尤其是在65岁及以上的老年人中很流行。人口老化更容易患心血管疾病，这正在推动对诊断和治疗程序的需求并推动市场成长。

医疗设备的技术进步对于推动市场成长至关重要。材料、设计和功能方面的创新正在开发更有效、更可靠的止血阀。例如，先进聚合物和涂层的使用使这些设备更加耐用和生物相容性，减少血栓症和感染疾病等併发症。此外，易于使用的锁定机构和增强的密封能力等新功能正在提高止血阀在临床环境中的效率。例如，波士顿科学公司的 WATCHDOG 止血阀采用创新的十字缝设计，最大限度地减少洩漏，并具有可同时容纳多个设备的 8F 内腔。此外，它还具有拇指休息功能，旨在增加手术过程中的舒适度。这些设计元素可减少失血和空气栓塞的风险，在整个医疗过程中始终将病患安全放在首位。

被优先考虑。这些技术改进将使手术更安全、更有效率，并鼓励止血阀的采用。

全球止血阀市场细分

该报告预测了2018年至2030年的收益成长情况，并分析了各个子区隔的最新趋势。在本报告中，Grand View Research, Inc. 根据类型、应用、最终用途和地区对全球止血阀市场报告进行了细分。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章：止血阀市场的变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 助剂市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 产业分析-波特五力分析
    • PESTEL分析
  • COVID-19对止血阀市场的影响
  • 价格分析

第四章止血阀市场：按类型估计和趋势分析

  • 细分仪表板
  • 止血阀市场：类型变化分析，2023 年和 2030 年

第五章止血阀市场：按应用、估计和趋势分析

  • 细分仪表板
  • 止血阀市场：2023 年和 2030 年应用变化分析

第六章止血阀市场：最终用途的估计和趋势分析

  • 细分仪表板
  • 止血阀市场：2023 年和 2030 年最终用途变化分析

第七章止血阀市场：区域估计及趋势分析

  • 2023 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 2023年主要企业市场占有率分析
    • Boston Scientific Corporation
    • Teleflex Incorporated
    • Merit Medical Systems
    • B. Braun Melsungen AG
    • TERUMO CORPORATION
    • Abbott
    • Argon Medical Devices
    • Freudenberg Medical
    • SCW Medicath Ltd
    • Lepu Medical Technology（Beijing）Co.,Ltd.
    • Nipro
    • DeRoyal Industries, Inc.
    • Antmed Corporation
    • Beijing Demax Medical Technology Co
Product Code: GVR-4-68040-342-2

Hemostasis Valve Market Size & Trends

The global hemostasis valve market size was estimated at USD 174.8 million in 2023 and is projected to grow at a CAGR of 5.8% from 2024 to 2030. The increasing prevalence of cardiovascular diseases, supportive regulatory frameworks, rising geriatric population, and technological advancements are significantly driving the market growth. According to the report published by World Heart Federation in 2023, cardiovascular diseases (CVDs) have a profound global impact, affecting over half a billion people worldwide and resulting in approximately 20.5 million deaths in 2021.This, in turn, drives the demand for diagnostic and therapeutic procedures like angiography and angioplasty, where hemostasis valves are essential to ensure patient safety by controlling blood flow during catheterization procedures.

The growing preference for minimally invasive procedures is another significant factor propelling the market growth. Minimally invasive techniques offer numerous benefits over traditional open surgeries, including reduced pain, shorter hospital stays, faster recovery times, and lower risk of complications. As a result, there is a heightened demand for medical devices that facilitate these procedures. Hemostasis valves are integral to minimally invasive catheter-based interventions, as they enable precise control of blood flow and prevent leakage during the procedure. The shift towards minimally invasive techniques in cardiology and other medical fields drives the adoption of hemostasis valves.

The global demographic landscape is undergoing a notable shift towards aging, driven by declining birth rates and advancements in healthcare that have prolonged life expectancy. According to the World Health Organization (WHO), the number of people aged 60 years and older is expected to double by 2050, reaching approximately 2.1 billion globally. This demographic transition underscores the increasing prevalence of age-related conditions, including cardiovascular diseases (CVDs) among older adults. According to the article published by the American Heart Association in November 2023, heart failure is a widespread and multifaceted cardiovascular condition impacting more than 6.7 million Americans, particularly prevalent among individuals aged 65 and older. The aging population is susceptibility to cardiovascular diseases drive the demand for diagnostic and therapeutic procedures, driving the market growth.

Technological advancements in medical devices are pivotal in driving the market growth. Materials, design, and functionality innovations have developed more effective and reliable hemostasis valves. For instance, using advanced polymers and coatings has improved the durability and biocompatibility of these devices, reducing complications such as thrombosis and infection. In addition, incorporating novel features such as easy-to-use locking mechanisms and enhanced sealing capabilities has increased the efficiency of hemostasis valves in clinical settings. For instance, the WATCHDOG Hemostasis Valve by Boston Scientific Corporation incorporates an innovative cross-slit design to minimize leakage, complemented by an 8F inner lumen that simultaneously accommodates multiple devices. In addition, it includes a thumb rest feature designed for enhanced comfort during procedures. The design elements collectively contribute to reducing blood loss and the risk of air embolism, prioritizing patient safety throughout medi

cal interventions. These technological improvements ensure that procedures are safer and more efficient, boosting the adoption of hemostasis valves.

Global Hemostasis Valve Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global hemostasis valve market report based on type, application, end-use, and regions.

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Hemostasis Valve Y- Connectors
  • Double Y- Connector Hemostasis Valves
  • One- Handed Hemostasis Valves
  • Others
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Angiography
  • Angioplasty
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

Japan

China

India

South Korea

Australia

Thailand

  • Latin America

Brazil

Argentina

  • Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hemostasis Valve Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Industry Analysis - Porter's
      • 3.2.3.1. Bargaining power of the suppliers
      • 3.2.3.2. Bargaining power of the buyers
      • 3.2.3.3. Threats of substitution
      • 3.2.3.4. Threats from new entrants
      • 3.2.3.5. Competitive rivalry
    • 3.2.4. PESTEL Analysis
      • 3.2.4.1. Political landscape
      • 3.2.4.2. Economic and Social landscape
      • 3.2.4.3. Technological landscape
  • 3.3. Impact of COVID-19 on the Hemostasis Valve Market
  • 3.4. Pricing Analysis

Chapter 4. Hemostasis Valve Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Hemostasis Valve Market: Type Movement Analysis, 2023 & 2030 (USD Million)
    • 4.2.1. Hemostasis Valve Y- Connectors
      • 4.2.1.1. Hemostasis Valve Y- Connectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Double Y - Connector Hemostasis Valves
      • 4.2.2.1. Double Y - Connector Hemostasis Valves Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.3. One-Handed Hemostasis Valves
      • 4.2.3.1. One-Handed Hemostasis Valves Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.4. Others
      • 4.2.4.1. Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Hemostasis Valve Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Hemostasis Valve Market: Application Movement Analysis, 2023 & 2030 (USD Million)
    • 5.2.1. Angiography
      • 5.2.1.1. Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.2. Angioplasty
      • 5.2.2.1. Angioplasty Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.3. Angioplasty
      • 5.2.3.1. Angioplasty Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Hemostasis Valve Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Hemostasis Valve Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
    • 6.2.1. Hospitals
      • 6.2.1.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. Ambulatory Surgical Centers
      • 6.2.2.1. Ambulatory Surgical Centers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Others
      • 6.2.3.1. Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Hemostasis Valve Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key company market share analysis, 2023
    • 8.3.2. Boston Scientific Corporation
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Type benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Teleflex Incorporated
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Type benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Merit Medical Systems
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Type benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. B. Braun Melsungen AG
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Type benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. TERUMO CORPORATION
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Type benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Abbott
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Type benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Argon Medical Devices
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Type benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Freudenberg Medical
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Type benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. SCW Medicath Ltd
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Type benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Lepu Medical Technology (Beijing)Co.,Ltd.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Type benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Nipro
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Type benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. DeRoyal Industries, Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Type benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Antmed Corporation
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Type benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. Beijing Demax Medical Technology Co
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Type benchmarking
      • 8.3.15.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 Global Hemostasis Valve Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 Global Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 8 North America Hemostasis Valve Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 North America Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 11 North America Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 12 U.S. Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 U.S. Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15 Canada Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 16 Canada Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 17 Canada Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18 Europe Hemostasis Valve Market, By Country, 2018 - 2030 (USD Million)
  • Table 19 Europe Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 20 Europe Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 21 Europe Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 22 UK Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 UK Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 UK Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 25 Germany Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 Germany Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 Germany Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28 France Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 29 France Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 France Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 31 Italy Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 Italy Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 Italy Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 34 Spain Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 Spain Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Spain Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37 Denmark Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 Denmark Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 Denmark Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 40 Sweden Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 41 Sweden Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 42 Sweden Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43 Norway Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 44 Norway Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 Norway Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Hemostasis Valve Market, By Country, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 50 Japan Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Japan Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 Japan Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 53 China Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 China Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 China Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56 India Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 57 India Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 India Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59 South Korea Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 South Korea Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 61 South Korea Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 62 Australia Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 Australia Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 Australia Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65 Thailand Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 66 Thailand Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 67 Thailand Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 68 Latin America Hemostasis Valve Market, By Country, 2018 - 2030 (USD Million)
  • Table 69 Latin America Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 70 Latin America Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 71 Latin America Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 72 Brazil Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 73 Brazil Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 74 Brazil Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 75 Argentina Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 76 Argentina Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 77 Argentina Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 78 Mexico Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 79 Mexico Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 80 Mexico Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 81 Middle East and Africa Hemostasis Valve Market, By Country, 2018 - 2030 (USD Million)
  • Table 82 Middle East and Africa Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 83 Middle East and Africa Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 85 South Africa Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 86 South Africa Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 87 South Africa Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 91 UAE Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 92 UAE Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 93 UAE Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Hemostasis Valve market segment scope and defination
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2023)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Hemostasis valve market: Type movement analysis
  • Fig. 17 Hemostasis valve market: Type segment dashboard
  • Fig. 18 Hemostasis valve market Type outlook: Key takeaways
  • Fig. 19 Hemostasis valve Y- connectors hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Double Y- Connector hemostasis valves market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 One- Handed hemostasis valves market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Tissue retractors hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Other hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Hemostasis Valve market: Application movement analysis
  • Fig. 25 Hemostasis Valve market Application outlook: Key takeaways
  • Fig. 26 Angiography hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Angioplasty hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Hemostasis Valve market: End use movement analysis
  • Fig. 29 Hemostasis Valve market End use outlook: Key takeaways
  • Fig. 30 Hospitals Hemostasis Valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Ambulatory surgical centers hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Other hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Regional outlook, 2023 & 2030
  • Fig. 34 Regional market dashboard
  • Fig. 35 Regional market place: Key takeaways
  • Fig. 36 North America Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 40 UK Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 43 France Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy implantable Market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 50 China Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 51 India Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 53 Australia Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 57 Mexico Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 59 MEA Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 61 Saudi Arabia Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 62 UAE Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 63 Kuwait Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 64 Heat map analysis
  • Fig. 65 Market differentiators